The prominent KMT2A rearrangement partner, MLLT3, is the most common of all KMT2A rearrangements in infant AML and is associated with both myelomonocytic leukemia (AMML) and AMKL [87,94]. Here, KMT2A is linked to acute myeloid leukemia.